100 related articles for article (PubMed ID: 2787203)
1. Enhanced in vivo therapeutic response to interferon in mice with an in vitro interferon-resistant B-cell lymphoma.
Reid TR; Race ER; Wolff BH; Friedman RM; Merigan TC; Basham TY
Cancer Res; 1989 Aug; 49(15):4163-9. PubMed ID: 2787203
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action.
Basham TY; Race ER; Campbell MJ; Reid TR; Levy R; Merigan TC
J Immunol; 1988 Oct; 141(8):2855-60. PubMed ID: 2971732
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.
Landolfo S; Gariglio M; Gribaudo G; Jemma C; Giovarelli M; Cavallo G
Eur J Immunol; 1988 Apr; 18(4):503-9. PubMed ID: 2835246
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of interferon-resistant variants from S49 mouse lymphoma.
Hochman J; Mador N; Gloger I; Falk H; Panet A
Exp Cell Res; 1988 Jul; 177(1):37-46. PubMed ID: 2455652
[TBL] [Abstract][Full Text] [Related]
5. Enhanced in vivo sensitivity of in vitro interferon-treated B16 melanoma cells to CD8 cells and activated macrophages.
Fleischmann CM; Stanton GJ; Fleischmann WR
J Interferon Cytokine Res; 1996 Oct; 16(10):805-12. PubMed ID: 8910765
[TBL] [Abstract][Full Text] [Related]
6. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
7. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomas.
Basham TY; Palladino MA; Badger CC; Bernstein ID; Levy R; Merigan TC
Cancer Res; 1988 Aug; 48(15):4196-200. PubMed ID: 2455592
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
Basham TY; Kaminski MS; Kitamura K; Levy R; Merigan TC
J Immunol; 1986 Nov; 137(9):3019-24. PubMed ID: 3760580
[TBL] [Abstract][Full Text] [Related]
10. Close link between reduction of c-myc expression by interferon and, G0/G1 arrest.
Einat M; Resnitzky D; Kimchi A
Nature; 1985 Feb 14-20; 313(6003):597-600. PubMed ID: 3881681
[TBL] [Abstract][Full Text] [Related]
11. Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma.
Dunk AA; Ikeda T; Pignatelli M; Thomas HC
J Hepatol; 1986; 2(3):419-29. PubMed ID: 3013985
[TBL] [Abstract][Full Text] [Related]
12. Effect of mouse interferon alpha/beta on the expression of H-2 (class I) antigens and on the levels of 2'-5' oligoadenylate synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
Locardi C; Belardelli F; Federico M; Romeo G; Affabris E; Gresser I
J Biol Regul Homeost Agents; 1987; 1(4):189-94. PubMed ID: 3332546
[TBL] [Abstract][Full Text] [Related]
13. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
14. Response of L-1210 tumor in mice toward treatment with interferon or poly(I) X poly(C).
Rivière Y; Hovanessian A
J Interferon Res; 1983; 3(4):417-24. PubMed ID: 6672113
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
16. Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines.
Groveman DS; Borden EC; Merritt JA; Robins HI; Steeves R; Bryan GT
Cancer Res; 1984 Dec; 44(12 Pt 1):5517-21. PubMed ID: 6498814
[TBL] [Abstract][Full Text] [Related]
17. Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon.
Nagata Y; Rosen OM; Makman MH; Bloom BR
J Cell Biol; 1984 Apr; 98(4):1342-7. PubMed ID: 6325469
[TBL] [Abstract][Full Text] [Related]
18. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
19. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
[TBL] [Abstract][Full Text] [Related]
20. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
